Bml Capital Management, LLC Lava Therapeutics Nv Transaction History
Bml Capital Management, LLC
- $132 Billion
- Q2 2025
A detailed history of Bml Capital Management, LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Bml Capital Management, LLC holds 1,970,610 shares of LVTX stock, worth $3.02 Million. This represents 1.97% of its overall portfolio holdings.
Number of Shares
1,970,610
Previous 1,960,610
0.51%
Holding current value
$3.02 Million
Previous $2.49 Billion
4.47%
% of portfolio
1.97%
Previous 2.02%
Shares
2 transactions
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.95MCall Options Held
50.2KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$3.17 Million0.28% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$798,4670.28% of portfolio
-
Pathway Financial Advisors LLC103KShares$156,8250.02% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$99,4500.0% of portfolio
-
Two Sigma Investments, LP New York, NY57.7KShares$88,3030.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $39.5M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...